Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Lumify Generic Name & Formulations
Legal Class
OTC
General Description
Brimonidine tartrate 0.025%; oph soln; contains benzalkonium chloride.
Pharmacological Class
Alpha-2 agonist.
How Supplied
Soln—2.5mL, 7.5mL
Manufacturer
Generic Availability
NO
Lumify Indications
Indications
To relieve redness due to minor eye irritations.
Lumify Dosage and Administration
Adults and Children
<5yrs: consult physician. ≥5yrs: 1 drop in affected eye(s) every 6–8hrs; max 4 times daily.
Lumify Contraindications
Not Applicable
Lumify Boxed Warnings
Not Applicable
Lumify Warnings/Precautions
Warnings/Precautions
Discontinue if eye pain, vision changes, continued redness or irritation occurs. Reevaluate if condition worsens or persists >3 days. Remove contact lenses before use; may reinsert 10mins later. Pregnancy. Nursing mothers.
Lumify Pharmacokinetics
See Literature
Lumify Interactions
Interactions
Separate administration of other oph drugs by ≥5mins.
Lumify Adverse Reactions
Not Applicable
Lumify Clinical Trials
See Literature
Lumify Note
Not Applicable
Lumify Patient Counseling
See Literature
